X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (446) 446
Patent (354) 354
Music Score (54) 54
Publication (51) 51
Book / eBook (18) 18
Web Resource (15) 15
Streaming Audio (14) 14
Book Review (12) 12
Magazine Article (12) 12
Book Chapter (10) 10
Conference Proceeding (6) 6
Paper (4) 4
Newspaper Article (2) 2
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
chemistry (325) 325
metallurgy (322) 322
organic chemistry (216) 216
human necessities (206) 206
hygiene (195) 195
medical or veterinary science (195) 195
preparations for medical, dental, or toilet purposes (193) 193
heterocyclic compounds (176) 176
biochemistry (163) 163
microbiology (163) 163
enzymology (162) 162
beer (161) 161
mutation or genetic engineering (161) 161
spirits (161) 161
vinegar (161) 161
wine (161) 161
specific therapeutic activity of chemical compounds ormedicinal preparations (144) 144
humans (143) 143
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (133) 133
processes using microorganisms (128) 128
index medicus (124) 124
female (114) 114
culture media (113) 113
compositions thereof (112) 112
microorganisms or enzymes (112) 112
propagating, preserving or maintaining microorganisms (112) 112
middle aged (82) 82
aged (74) 74
oncology (73) 73
adult (66) 66
acyclic or carbocyclic compounds (58) 58
breast neoplasms - drug therapy (55) 55
male (51) 51
antineoplastic combined chemotherapy protocols - therapeutic use (46) 46
breast cancer (46) 46
treatment outcome (42) 42
chemotherapy (40) 40
disease-free survival (40) 40
wheat (34) 34
breast neoplasms - pathology (33) 33
chemotherapy, adjuvant (32) 32
apparatus therefor (30) 30
general methods of organic chemistry (30) 30
therapy (29) 29
care and treatment (28) 28
general tagging of cross-sectional technologies spanning over several sections of the ipc (28) 28
general tagging of new technological developments (28) 28
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (28) 28
research (27) 27
aged, 80 and over (26) 26
analysis (26) 26
antineoplastic combined chemotherapy protocols - adverse effects (25) 25
follow-up studies (25) 25
foods or foodstuffs (25) 25
prognosis (25) 25
technical subjects covered by former uspc (25) 25
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (25) 25
their treatment, not covered by other classes (25) 25
fodder (24) 24
animals (23) 23
chromosomes (23) 23
survival (23) 23
kaplan-meier estimate (21) 21
cancer (20) 20
breast neoplasms - mortality (19) 19
plant sciences (19) 19
trastuzumab (19) 19
clinical trials (18) 18
agriculture (17) 17
drug therapy (17) 17
genomics (17) 17
neoplasm staging (17) 17
survival analysis (17) 17
breast neoplasms - surgery (16) 16
double-blind method (16) 16
life sciences (16) 16
survival rate (16) 16
agronomy (15) 15
antineoplastic agents - therapeutic use (15) 15
article (15) 15
breast neoplasms - chemistry (15) 15
drug administration schedule (15) 15
medicine & public health (15) 15
metastasis (15) 15
patients (15) 15
proportional hazards models (15) 15
surgery (15) 15
barley (14) 14
classical music (14) 14
fluorouracil - administration & dosage (14) 14
genes (14) 14
genetic aspects (14) 14
genomes (14) 14
hematology, oncology and palliative medicine (14) 14
physiological aspects (14) 14
triticum - genetics (14) 14
antineoplastic combined chemotherapy protocols - administration & dosage (13) 13
bevacizumab (13) 13
fluorescence in situ hybridization (13) 13
genetic research (13) 13
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Music - Stacks (37) 37
Online Resources - Online (15) 15
UTL at Downsview - May be requested (15) 15
Robarts - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Stacks (1) 1
Innis College - Stacks (1) 1
Music - May be requested in 6-10 wks (1) 1
Victoria University E.J. Pratt - Oversize (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (662) 662
Hungarian (99) 99
German (68) 68
French (47) 47
Finnish (22) 22
Italian (15) 15
Norwegian (14) 14
Danish (11) 11
Swedish (7) 7
Portuguese (6) 6
Spanish (6) 6
Japanese (5) 5
Turkish (4) 4
Bulgarian (3) 3
Czech (3) 3
Icelandic (3) 3
Slovak (3) 3
Romanian (2) 2
Arabic (1) 1
Polish (1) 1
Russian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Sports Science & Coaching, ISSN 1747-9541, 9/2010, Volume 5, Issue 3, pp. 389 - 402
The LTAD (Long Term Athlete Development) model has come to represent a sports-wide set of principles that significantly influences national sports policy in... 
Training Volume | Amateur Swimming Association | Swimming Technique | Fundamental Motor Skills | Istvan Balyi | SPORT | Istvan Balyi; Swimming Technique | ACQUISITION | PSYCHOLOGY, APPLIED | COMPETITIVE SWIMMERS | EXPERT PERFORMANCE | HOSPITALITY, LEISURE, SPORT & TOURISM | EXPERIENCE
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 25 - 35
Summary Background Palbociclib (PD-0332991) is an oral, small-molecule inhibitor of cyclin-dependent kinases (CDKs) 4 and 6 with preclinical evidence of... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | EXEMESTANE | ONCOLOGY | CELL-CYCLE | POSTMENOPAUSAL WOMEN | HER2 | PLUS | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Piperazines - administration & dosage | Triazoles - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Receptors, Estrogen - analysis | Molecular Targeted Therapy | North America | Nitriles - administration & dosage | Breast Neoplasms - enzymology | Time Factors | Postmenopause | Female | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Republic of Korea | Aromatase Inhibitors - administration & dosage | Pyridines - administration & dosage | Drug Administration Schedule | Administration, Oral | Biomarkers, Tumor - analysis | Europe | Proportional Hazards Models | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Treatment Outcome | Cyclin-Dependent Kinase 6 - metabolism | Cyclin-Dependent Kinase 4 - metabolism | Breast Neoplasms - drug therapy | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Breast Neoplasms - genetics | Cyclin D1 - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Intention to Treat Analysis | South Africa | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Care and treatment | Oncology, Experimental | Estrogen | Breast cancer | Research | Antineoplastic agents | Phosphotransferases | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1077 - 1085
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 6, pp. 580 - 591
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 10, pp. 1137 - 1146
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 2, pp. 122 - 131
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e13545 - e13545
Journal Article
by Galimberti, Viviana and Cole, Bernard F and Viale, Giuseppe and Veronesi, Paolo and Veronesi, Umberto and Veronesi, Andreas and Vicini, Elisa and Intra, Mattia and Mazzarol, Giovanni and Massarut, Samuele and Zgajnar, Janez and Taffurelli, Mario and Littlejohn, David and Knauer, Michael and Tondini, Carlo and Di Leo, Angelo and Colleoni, Marco and Regan, Meredith M and Coates, Alan S and Gelber, Richard D and Goldhirsch, Aron and Boyle, Fran and Jerusalem, Guy and Stahel, Rolf and Aebi, Stefan and Green, Michael and Karlsson, Per and Kössler, Ingrid and Láng, Istvan and Hiltbrunner, Anita and Bernhard, Jürg and Fournarakou, Stamatina and Kammler, Roswitha and Maibach, Rudolf and Rabaglio, Manuela and Ribi, Karin and Roschitzki, Heidi and Roux, Susanne and Ruepp, Barbara and Mahoney, Caitlin and Price, Karen and Blacher, Lynette and Scolese, Tara and Scott, Karolyn and Lippert, Sandra and Zielinski, Theresa and Mastropasqua, Mauro and Andrighetto, Stefania and Dell'Orto, Patrizia and Renne, Giuseppe and Pruneri, Giancarlo and Dellapasqua, Silvia and Iorfida, Monica and Cancello, Giuseppe and Montagna, Emilia and Cardillo, Anna and Peruzzotti, Giulia and Ghisini, Raffaella and Luini, Alberto and Gentilini, Oreste and Zurrida, Stefano and Curigliano, Giuseppe and Nole, Franco and Orecchia, Roberto and Leonardi, Marisa Cristina and Baratella, Paola and Chifu, Camelia and Sargenti, Manuela and Crivellari, Diana and Morassut, Sandro and Mileto, Mario and Piccoli, Erica and Magri, Marisa Donatella and Buonadonna, Angelo and Candiani, Ezio and Carbone, Antonino and Perin, Tiziana and Volpe, Rachele and Roncadin, Mario and Arcicasa, Mauro and Coran, Francesco and Lagrassa, Manuela and Recalcati, Angelo and Limonta, Maria Emanuela and Tricomi, Paolo and Fenaroli, Privato and Candiago, Elisabetta and Cattaneo, Laura and Gianatti, Alberto and Santini, Donatella and Maweja, Sylvie and Delvenne, Philippe and Rorive, Andrée and Collignon, Joëlle and Garbay, Jean-Remi and Mathieu, Marie-Christine and Galatius, Hanne and Hoffmann, Jack and Schousen, Peer and Lanng, Charlotte and ... and Int Breast Canc Study Grp Trial 23 and International Breast Cancer Study Group Trial 23-01
The Lancet Oncology, ISSN 1470-2045, 10/2018, Volume 19, Issue 10, pp. 1385 - 1393
We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial comparing disease-free survival in patients with breast cancer with one or more... 
SURGERY | WOMEN | MULTICENTER | METASTASIS | ONCOLOGY | LYMPH-NODES | BIOPSY | RECURRENCE | EORTC 10981-22023 AMAROS | Care and treatment | Cancer patients | Breast cancer | Analysis | Surgery
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10018, pp. 545 - 557
Summary Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with metastatic pancreatic ductal adenocarcinoma previously treated... 
Internal Medicine | PLUS GEMCITABINE | SURVIVAL | 5-FLUOROURACIL | MEDICINE, GENERAL & INTERNAL | ADENOCARCINOMA | 2ND-LINE CHEMOTHERAPY | OXALIPLATIN | PEP02 | DOCETAXEL | CARCINOMA | FOLFIRI | Leucovorin - administration & dosage | Humans | Middle Aged | Male | Fatigue - chemically induced | Diarrhea - chemically induced | Pancreatic Neoplasms - drug therapy | Neoplasm Metastasis | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Camptothecin - administration & dosage | Carcinoma, Pancreatic Ductal - mortality | Deoxycytidine - adverse effects | Female | Pancreatic Neoplasms - mortality | Neutropenia - chemically induced | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Pancreatic Ductal - drug therapy | Irinotecan | Vomiting - chemically induced | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Liposomes | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Pancreatic cancer | Leucovorin | Product development | Research institutes | Metastasis | Antineoplastic agents | Analysis | Antigens | Chemotherapy | Medical prognosis | Clinical trials | Drug dosages | Cancer therapies | Tumors | Adenocarcinoma | Slopes | Therapy | Gemcitabine | Toxicity | Metastases | Nanoparticles | Randomization | Motivation | Vomiting | Safety management | Toxic diseases | Neutropenia | Folinic acid | Lymphatic system | Medical treatment | Diarrhea | FDA approval | Survival | Patients | Acids | Equivalence | Interactive systems
Journal Article